Study to Investigate DRP-104 in Adults With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sunil Sharma, MD
HonorHealth Director
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centrum Fur Integrieerte Onkologie
Cologne, Germany
- University Cancer Center Nct
Dresden, Germany
- University Hospital Frankfurt
Frankfurt, Germany
- University Klinikum Wuerzburg
Würzburg, Germany
- National Cancer Center Singapore
Singapore, Singapore
- Hospital University Vall D'Hebron
Barcelona, Spain
- University Hospital 12 de Octubre
Madrid, Spain
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Honorhealth
Scottsdale, Arizona, United States
- Ucla
Los Angeles, California, United States
- Adventhealth Medical Group
Kissimmee, Florida, United States
- Florida Cancer Specialist
Orlando, Florida, United States
- Johns Hopkins Kimmel Institute
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Nyu Langone
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Next Oncology
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2020
- Primary completion
- 28 Mar 2023
- Completion
- 28 Mar 2023
- Last update posted
- 12 Jun 2023
- Registered enrollment
- 61
- Registry id
- NCT04471415
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.